Seer Inc (SEER)
1.77
-0.04
(-2.21%)
USD |
NASDAQ |
Apr 24, 16:00
1.775
0.00 (0.00%)
After-Hours: 20:00
Seer Revenue (TTM): 15.18M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 15.18M |
September 30, 2023 | 14.86M |
June 30, 2023 | 15.00M |
March 31, 2023 | 15.10M |
Date | Value |
---|---|
December 31, 2022 | 14.68M |
September 30, 2022 | 13.86M |
June 30, 2022 | 12.05M |
March 31, 2022 | 9.692M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
9.692M
Minimum
Mar 2022
15.18M
Maximum
Dec 2023
13.80M
Average
14.77M
Median
Revenue (TTM) Benchmarks
Candel Therapeutics Inc | -- |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.202M |
IGC Pharma Inc | 1.216M |
NovaBay Pharmaceuticals Inc | 14.73M |